fda bpc 157 category 2 compounding panel votes to place popular peptide BPC-157 on list FDA has removed certain bulk

FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Advisers Vote to Ease Restrictions on BPC 157, TB 500, and Other Novel Peptides Glitchwire This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy

SKU: 43758255390 · From iglepidom.org